|
February
Wednesday, Feb 24, 2010 Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer Monday, Feb 22, 2010 Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint Thursday, Feb 18, 2010 FDA Approves Rituxan Plus Chemotherapy for the Most Common Type of Adult Leukemia January Friday, Jan 15, 2010 FDA Extends Review Period for Tarceva Application for First-line Maintenance Use in Advanced Non-small Cell Lung Cancer Friday, Jan 08, 2010 FDA Approves ACTEMRA® (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis December Wednesday, Dec 16, 2009 FDA Advisory Committee Recommends Against Approving Tarceva for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer Saturday, Dec 12, 2009 New Phase II Study Showed Trastuzumab-DM1 Shrank Tumors in Women With Highly Advanced HER2-positive Breast Cancer Friday, Dec 11, 2009 Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Women Previously Treated with Chemotherapy for Advanced Breast Cancer See the Archives 
 |
